Introduction: The Foundation of Aluminum-Plastic Closure Standards
In the pharmaceutical packaging ecosystem, standards serve as the bedrock upon which product safety, quality, and regulatory compliance are built. Among the most critical standards governing closure systems is ISO 10985:2009 – Caps made of aluminium-plastics combinations for infusion bottles and injection vials – Requirements and test methods. This standard establishes the essential framework for aluminum-plastic combination caps used on injection vials and infusion bottles, ensuring that these closures deliver the performance, integrity, and patient safety that the pharmaceutical industry demands.
At Vialab Pharmaceutical Packaging Co., Ltd. , we design and manufacture aluminum-plastic combination caps in full compliance with international standards including ISO 10985:2009. Our advanced production lines and cleanroom facilities enable us to produce closures that meet the rigorous requirements of this standard, ensuring consistent quality, integrity, and compliance for global healthcare partners.
This article provides a comprehensive examination of ISO 10985:2009, exploring its scope, purpose, key requirements, test methods, and its relationship with other standards in the pharmaceutical packaging ecosystem.
1. Scope and Applicability
ISO 10985:2009 specifies general requirements and test methods for caps made of aluminium-plastics combinations intended for use on infusion bottles (as specified in ISO 8536-1) and/or injection vials (as specified in ISO 8362-1 and ISO 8362-4). The caps covered by this standard are manufactured in accordance with either:
- ISO 8536-7 – Infusion equipment for medical use — Caps made of aluminium-plastics combinations for infusion bottles
- ISO 8362-6 – Injection containers and accessories — Caps made of aluminium-plastics combinations for injection vials
This dual applicability reflects the standard’s comprehensive approach to aluminum-plastic closure systems across both infusion and injection applications. The standard applies to caps that combine an aluminum outer shell with a plastic component—typically a flip-off button, tear-off tab, or sealing gasket—creating a hybrid closure that leverages the strengths of both materials.
2. The Four Essential Purposes of ISO 10985:2009
According to the standard, aluminum-plastic combination caps must fulfill four critical purposes:
2.1 Guarantee of Originality of the Closure
The cap must provide unmistakable evidence of tampering or prior opening up to the point of administration. This tamper-evident functionality is essential for patient safety, as it ensures that the drug product has not been compromised before use. The aluminum-plastic combination design achieves this through features such as tear-off tabs or flip-off buttons that break or separate upon first opening, providing visible, irreversible evidence of access.
2.2 Compression of the Sealing Element
The cap must maintain compression of the rubber stopper (the sealing element) against the sealing surfaces of the infusion bottle or injection vial. This compression is critical for maintaining container closure integrity throughout the product’s shelf life. The aluminum skirt, when crimped, provides the mechanical force that holds the stopper in place, while the plastic component ensures that this compression is maintained without over-compression that could compromise the stopper’s integrity.
2.3 Protection of the Sealing Element
The cap must protect the rubber stopper against soiling and mechanical damage prior to use. The aluminum-plastic combination design creates a robust barrier that shields the stopper’s penetration area from contamination, physical damage, and environmental factors that could compromise sterility.
2.4 Simple and Injury-Free Opening
The cap must enable simple, injury-free opening to expose the penetration area of the rubber closure or to permit total removal of the cap. This requirement addresses healthcare provider and patient safety, ensuring that the closure can be opened without the need for sharp instruments or excessive force that could cause injury. The plastic flip-off or tear-off design facilitates this ease of use while maintaining security.
3. Key Technical Requirements
While the full text of ISO 10985:2009 spans multiple sections, its core requirements can be grouped into several critical categories:
3.1 Material Requirements
The aluminum component must be manufactured from pharmaceutical-grade aluminum alloys with specified mechanical properties. The plastic component—typically polypropylene (PP), high-density polyethylene (HDPE), or low-density polyethylene (LDPE)—must demonstrate compatibility with pharmaceutical applications, including resistance to sterilization processes and stability over the product’s shelf life.
3.2 Dimensional Requirements
The standard specifies dimensional tolerances for critical features including:
- Cap outer diameter and height
- Skirt dimensions and thickness
- Plastic component dimensions and fit
- Overall cap geometry to ensure proper fitment with ISO-compliant vials and bottles
3.3 Mechanical Performance Requirements
Opening Force: The force required to remove the plastic component (flip-off or tear-off) must fall within specified ranges—typically 20–60 N—to ensure that the cap is both secure and user-friendly. This balance is critical: too low a force compromises tamper evidence and security; too high a force creates difficulty for healthcare providers and may lead to injury.
Tensile Strength and Elongation: The aluminum component must demonstrate adequate tensile strength (100–180 N/mm²) and elongation (not less than 2.0%) to withstand the crimping process and maintain sealing function.
Combination Integrity: The bond between the aluminum and plastic components must withstand normal handling, transportation, and storage without delamination or separation.
3.4 Sterilization Compatibility
Aluminum-plastic combination caps must withstand the sterilization methods used for the finished drug product. This typically includes:
- Moist heat sterilization at 121°C
- Irradiation sterilization (which must not change the mechanical properties of the plastic component)
- Ethylene oxide sterilization (where applicable)
Surface coatings on the aluminum component must remain stable through sterilization cycles without degradation or flaking.
4. Test Methods Specified in ISO 10985:2009
ISO 10985:2009 establishes specific test methods to verify that aluminum-plastic combination caps meet the standard’s requirements. These include:
4.1 Opening Force Testing
Specialized testing equipment measures the force required to remove the plastic component (flip-off button or tear-off tab). This test ensures that the opening force falls within the specified range. The Injection Vial Cap Open Force Tester is a common instrument used for this purpose, designed specifically to evaluate the opening force required for aluminum-plastic combination caps.
4.2 Dimensional Verification
Critical dimensions are measured using calibrated instruments to ensure compliance with specified tolerances. This includes verification of fitment with the specific vial-stopper-cap combination.
4.3 Visual Inspection
Caps are inspected visually for defects including:
- Surface imperfections
- Coating integrity
- Proper assembly of aluminum and plastic components
- Tamper-evident feature integrity
4.4 Crimping Performance Verification
The cap’s performance during crimping is verified using actual production vial-stopper-cap systems. This ensures that the cap crimps properly without cracking, fracturing, or compromising the seal.
4.5 Container Closure Integrity (CCI) Testing
While ISO 10985:2009 focuses on the cap itself, the cap’s performance is ultimately evaluated as part of the complete container closure system. USP <671> outlines procedures for evaluating container closure system integrity, including visual inspection, dye penetration, and helium leak testing. ISO 11607-1 and ISO 11607-2 provide comprehensive guidelines for the design, testing, and validation of sterile barrier systems, including closures.
5. Relationship with Other Standards
5.1 ISO 8362-6 and ISO 8536-7
ISO 10985:2009 works in conjunction with ISO 8362-6 (for injection vials) and ISO 8536-7 (for infusion bottles). These standards specify the dimensional and performance requirements for the caps themselves, while ISO 10985:2009 provides the overarching requirements and test methods that apply across both applications.
5.2 ISO 8872:2022 – The Successor Standard
It is important to note that ISO 10985:2009 has been withdrawn and superseded by ISO 8872:2022. The 2022 edition consolidates and replaces both ISO 8872:2003 (which covered aluminum caps) and ISO 10985:2009 (which covered aluminum-plastic combination caps). This consolidation reflects the industry’s recognition that aluminum caps and aluminum-plastic combination caps share many fundamental requirements and test methods.
The 2022 edition introduces several enhancements:
- New terminology definitions
- Updated test method annexes
- Clarified material grading requirements
- Enhanced sterilization compatibility provisions
Despite being superseded, ISO 10985:2009 remains relevant as the foundational document that established the requirements for aluminum-plastic combination caps, and many manufacturers continue to reference it alongside ISO 8872:2022.
5.3 USP Standards
In the United States, USP <381> (Elastomeric Closures for Injections) and USP <671> (Containers—Performance Testing) provide complementary requirements for closure systems. USP <382> separates functional testing from material characterization, providing a comprehensive framework for closure system validation.
6. Practical Implications for Pharmaceutical Manufacturers
6.1 Regulatory Compliance
Compliance with ISO 10985:2009 (or its successor ISO 8872:2022) is essential for regulatory submissions worldwide. Regulatory authorities expect that closure systems meet internationally recognized standards, and deviation from these standards requires extensive justification.
6.2 Supplier Qualification
When selecting a supplier for aluminum-plastic combination caps, pharmaceutical manufacturers should verify that the supplier’s products meet the requirements of ISO 10985:2009/ISO 8872:2022. This includes reviewing:
- Material certifications
- Dimensional inspection reports
- Mechanical test results (opening force, tensile strength, elongation)
- Sterilization validation data
- Container closure integrity test results
6.3 Product Development
For new drug products, the selection of the closure system should be guided by ISO 10985:2009/ISO 8872:2022 requirements. Factors to consider include:
- Compatibility with the specific vial or bottle design
- Suitability for the intended sterilization method
- Opening force requirements for the target user population
- Tamper-evident feature requirements
6.4 Quality Control
Manufacturers should implement quality control programs that verify ongoing compliance with the standard. This includes:
- Incoming inspection of caps
- In-process monitoring during capping operations
- Finished product testing (including CCI testing)
- Periodic revalidation of the capping process
7. Vialab’s Commitment to Standards Compliance
At Vialab Pharmaceutical Packaging Co., Ltd. , we recognize that compliance with ISO 10985:2009 and its successor ISO 8872:2022 is not merely a regulatory obligation—it is a fundamental commitment to patient safety and product quality.
Our aluminum-plastic combination caps are manufactured to meet the stringent requirements of these standards, with:
- Pharmaceutical-grade aluminum alloys meeting specified mechanical properties
- High-quality plastic components validated for pharmaceutical applications
- Precision manufacturing ensuring dimensional accuracy
- Comprehensive testing including opening force, dimensional verification, and visual inspection
- Cleanroom manufacturing ensuring product cleanliness and sterility
Whether you require standard 13 mm or 20 mm aluminum-plastic combination caps or customized solutions for specialized applications, Vialab delivers precision, safety, and reliability in every component.
Conclusion
ISO 10985:2009 established the foundational requirements for aluminum-plastic combination caps used on injection vials and infusion bottles. Its four essential purposes—guaranteeing originality, maintaining stopper compression, protecting the sealing element, and enabling safe opening—remain as relevant today as when the standard was published.
While ISO 10985:2009 has been superseded by ISO 8872:2022, its principles and test methods continue to inform the design, manufacture, and qualification of aluminum-plastic combination caps worldwide. For pharmaceutical manufacturers, understanding these requirements is essential for ensuring product quality, regulatory compliance, and patient safety.
As the pharmaceutical packaging industry continues to evolve, the standards that govern it will also advance. At Vialab, we remain committed to staying at the forefront of these developments, ensuring that our products meet the highest standards of quality, safety, and performance.
References
- ISO 10985:2009 – Caps made of aluminium-plastics combinations for infusion bottles and injection vials — Requirements and test methods
- ISO 8872:2022 – Aluminium caps and aluminium/plastic caps for infusion bottles and injection vials — General requirements and test methods
- ISO 8362-6:2010 – Injection containers and accessories — Part 6: Caps made of aluminium-plastics combinations for injection vials
- ISO 8536-7:2009 – Infusion equipment for medical use — Part 7: Caps made of aluminium-plastics combinations for infusion bottles
- USP <671> – Containers — Performance Testing
- USP <381> – Elastomeric Closures for Injections
- USP <1207> – Container Closure Integrity Testing
- ISO 11607-1 and ISO 11607-2 – Packaging for terminally sterilized medical devices
This article is provided for informational purposes only and does not constitute regulatory advice. Manufacturers should consult with qualified experts and regulatory authorities for specific product validation and compliance.